Recipharm

Recipharm acquires Flamel Technologies facility in France

Monday, December 1, 2014 12:57 PM

Recipharm, a contract development and manufacturing organization based in Sweden, will purchase Flamel Technologies’ development and manufacturing facility in Pessac, France. Recipharm also will provide development and manufacturing support to Flamel under a long-term services agreement.

More... »


Recipharm acquires Lusomedicamenta

Friday, November 14, 2014 02:21 PM

Recipharm, a Swedish pharmaceutical contract development and manufacturing organization (CDMO), has acquired Lisbon, Portugal-based CDMO Lusomedicamenta Sociedade Técnica Farmacêutica.

More... »


Recipharm to acquire Corvette Pharmaceutical Services Group for $159.4M

Wednesday, August 20, 2014 01:15 PM

Recipharm, a Sweden-based contract development and manufacturing organization, has signed an agreement to acquire Milan-based Corvette Pharmaceutical Services Group from Italian private equity group LBO Italia Investimenti.

More... »

Recipharm, CTC form new collaboration

Thursday, June 19, 2014 01:49 PM

CTC Clinical Trial Consultants and Recipharm Pharmaceutical Development have entered into a collaboration.

More... »

Recipharm, Synthonics to promote novel drug delivery technology

Wednesday, May 8, 2013 09:40 AM

Recipharm Pharmaceutical, a Swedish contract development and manufacturing organization (CDMO), and Synthonics, a specialty pharmaceutical company based in Blacksburg, Va., have formed a Joint Promotion Agreement.

More... »

Recipharm appoints Lennernäs to operating board

Wednesday, February 6, 2013 12:38 PM

Recipharm, a contract development and manufacturing organization based in Sweden, has appointed Dr. Hans Lennernäs to the operating board of Recipharm Pharmaceutical Development.

More... »

Recipharm invests in analytical development services

Monday, December 10, 2012 11:27 AM

Recipharm, a contract development and manufacturing organization based in Sweden, has invested in expanding its capacity in analytical services and stability studies at its facility in Solna, Sweden.

More... »

Recipharm, Astimex form development and manufacturing collaboration

Friday, October 12, 2012 11:58 AM

Recipharm, a Swedish contract development and manufacturing organization, and Astimex Pharma, a Swedish pharmaceutical company, have formed a collaboration agreement for the development and manufacture of a pharmaceutical product.

More... »

Recipharm secures financing for future growth

Friday, May 25, 2012 11:32 AM

Recipharm, an international pharmaceutical contract development and manufacturing organization, has arranged a five-year $113 million loan facility with Swedbank, one of the largest banks in Sweden.

More... »

ViroPharma contracts Recipharm to manufacture Plenadren

Monday, March 19, 2012 09:56 AM

Recipharm, the international contract pharmaceutical development and manufacturing organization, has been contracted by ViroPharma to complete commercial scale-up manufacture of Plenadren (hydrocortisone), used for the treatment of adrenal insufficiency in adults.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 22

DaVita combines its two research CRO units to create an end-to-end CRO focused on kidney, end-stage renal disease

New crop of clinical trial matching services use patient’s molecular, genomic data for better fit

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs